US Stock MarketDetailed Quotes

LBPH Longboard Pharmaceuticals

Watchlist
  • 19.730
  • -0.670-3.28%
Close May 22 16:00 ET
  • 19.500
  • -0.230-1.17%
Post 19:28 ET
767.10MMarket Cap-8768P/E (TTM)

Longboard Pharmaceuticals Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
(Q2)Jun 30, 2022
Total revenue
0
0
0
0
0
0
0
0
0
0
Operating revenue
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Cost of revenue
Gross profit
Operating expense
51.40%18.11M
26.70%56.76M
32.80%15.57M
14.29%13.58M
35.23%15.64M
24.35%11.96M
60.92%44.8M
33.35%11.73M
87.00%11.88M
65.55%11.57M
Selling and administrative expenses
43.94%4.94M
28.02%13.01M
33.19%3.38M
24.71%3.09M
17.38%3.11M
37.33%3.43M
25.98%10.16M
4.45%2.53M
9.68%2.48M
27.70%2.65M
-General and administrative expense
43.94%4.94M
28.02%13.01M
33.19%3.38M
24.71%3.09M
17.38%3.11M
37.33%3.43M
25.98%10.16M
4.45%2.53M
9.68%2.48M
27.70%2.65M
Research and development costs
54.40%13.17M
26.31%43.75M
32.69%12.2M
11.54%10.49M
40.52%12.54M
19.79%8.53M
75.17%34.64M
44.36%9.19M
129.73%9.4M
81.51%8.92M
Operating profit
-51.40%-18.11M
-26.70%-56.76M
-32.80%-15.57M
-14.29%-13.58M
-35.23%-15.64M
-24.35%-11.96M
-60.92%-44.8M
-33.35%-11.73M
-87.00%-11.88M
-65.55%-11.57M
Net non-operating interest income expense
507.17%3.13M
187.34%2.41M
45.01%567K
130.66%662K
419.69%660K
1,512.50%516K
1,207.81%837K
1,529.17%391K
1,147.83%287K
876.92%127K
Non-operating interest income
507.17%3.13M
187.34%2.41M
45.01%567K
130.66%662K
419.69%660K
1,512.50%516K
1,207.81%837K
1,529.17%391K
1,147.83%287K
876.92%127K
Other net income (expense)
10.00%-9K
-525.00%-68K
-200.00%-27K
-1,500.00%-14K
-151.52%-17K
-11.11%-10K
172.73%16K
-200.00%-9K
107.69%1K
650.00%33K
Other non- operating income (expenses)
10.00%-9K
-525.00%-68K
-200.00%-27K
-1,500.00%-14K
-151.52%-17K
-11.11%-10K
172.73%16K
-200.00%-9K
107.69%1K
650.00%33K
Income before tax
-30.81%-14.99M
-23.84%-54.42M
-32.51%-15.03M
-11.54%-12.93M
-31.49%-15M
-19.37%-11.46M
-58.09%-43.95M
-29.32%-11.35M
-82.76%-11.6M
-63.42%-11.41M
Income tax
Net income
-30.81%-14.99M
-23.84%-54.42M
-32.51%-15.03M
-11.54%-12.93M
-31.49%-15M
-19.37%-11.46M
-58.09%-43.95M
-29.32%-11.35M
-82.76%-11.6M
-63.42%-11.41M
Net income continuous Operations
-30.81%-14.99M
-23.84%-54.42M
-32.51%-15.03M
-11.54%-12.93M
-31.49%-15M
-19.37%-11.46M
-58.09%-43.95M
-29.32%-11.35M
-82.76%-11.6M
-63.42%-11.41M
Minority interest income
Net income attributable to the parent company
-30.81%-14.99M
-23.84%-54.42M
-32.51%-15.03M
-11.54%-12.93M
-31.49%-15M
-19.37%-11.46M
-58.09%-43.95M
-29.32%-11.35M
-82.76%-11.6M
-63.42%-11.41M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
-30.81%-14.99M
-23.84%-54.42M
-32.51%-15.03M
-11.54%-12.93M
-31.49%-15M
-19.37%-11.46M
-58.09%-43.95M
-29.32%-11.35M
-82.76%-11.6M
-63.42%-11.41M
Basic earnings per share
25.00%-0.42
6.64%-2.39
6.06%-0.62
19.12%-0.55
2.99%-0.65
0.00%-0.56
-32.64%-2.56
-26.92%-0.66
-78.95%-0.68
-63.41%-0.67
Diluted earnings per share
25.00%-0.42
6.64%-2.39
6.06%-0.62
19.12%-0.55
2.99%-0.65
0.30%-0.56
-32.64%-2.56
-26.92%-0.66
-78.95%-0.68
-63.41%-0.67
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
--
(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022(Q2)Jun 30, 2022
Total revenue 0000000000
Operating revenue --0--0--0--0--0--0--0--0--0--0
Cost of revenue
Gross profit
Operating expense 51.40%18.11M26.70%56.76M32.80%15.57M14.29%13.58M35.23%15.64M24.35%11.96M60.92%44.8M33.35%11.73M87.00%11.88M65.55%11.57M
Selling and administrative expenses 43.94%4.94M28.02%13.01M33.19%3.38M24.71%3.09M17.38%3.11M37.33%3.43M25.98%10.16M4.45%2.53M9.68%2.48M27.70%2.65M
-General and administrative expense 43.94%4.94M28.02%13.01M33.19%3.38M24.71%3.09M17.38%3.11M37.33%3.43M25.98%10.16M4.45%2.53M9.68%2.48M27.70%2.65M
Research and development costs 54.40%13.17M26.31%43.75M32.69%12.2M11.54%10.49M40.52%12.54M19.79%8.53M75.17%34.64M44.36%9.19M129.73%9.4M81.51%8.92M
Operating profit -51.40%-18.11M-26.70%-56.76M-32.80%-15.57M-14.29%-13.58M-35.23%-15.64M-24.35%-11.96M-60.92%-44.8M-33.35%-11.73M-87.00%-11.88M-65.55%-11.57M
Net non-operating interest income expense 507.17%3.13M187.34%2.41M45.01%567K130.66%662K419.69%660K1,512.50%516K1,207.81%837K1,529.17%391K1,147.83%287K876.92%127K
Non-operating interest income 507.17%3.13M187.34%2.41M45.01%567K130.66%662K419.69%660K1,512.50%516K1,207.81%837K1,529.17%391K1,147.83%287K876.92%127K
Other net income (expense) 10.00%-9K-525.00%-68K-200.00%-27K-1,500.00%-14K-151.52%-17K-11.11%-10K172.73%16K-200.00%-9K107.69%1K650.00%33K
Other non- operating income (expenses) 10.00%-9K-525.00%-68K-200.00%-27K-1,500.00%-14K-151.52%-17K-11.11%-10K172.73%16K-200.00%-9K107.69%1K650.00%33K
Income before tax -30.81%-14.99M-23.84%-54.42M-32.51%-15.03M-11.54%-12.93M-31.49%-15M-19.37%-11.46M-58.09%-43.95M-29.32%-11.35M-82.76%-11.6M-63.42%-11.41M
Income tax
Net income -30.81%-14.99M-23.84%-54.42M-32.51%-15.03M-11.54%-12.93M-31.49%-15M-19.37%-11.46M-58.09%-43.95M-29.32%-11.35M-82.76%-11.6M-63.42%-11.41M
Net income continuous Operations -30.81%-14.99M-23.84%-54.42M-32.51%-15.03M-11.54%-12.93M-31.49%-15M-19.37%-11.46M-58.09%-43.95M-29.32%-11.35M-82.76%-11.6M-63.42%-11.41M
Minority interest income
Net income attributable to the parent company -30.81%-14.99M-23.84%-54.42M-32.51%-15.03M-11.54%-12.93M-31.49%-15M-19.37%-11.46M-58.09%-43.95M-29.32%-11.35M-82.76%-11.6M-63.42%-11.41M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders -30.81%-14.99M-23.84%-54.42M-32.51%-15.03M-11.54%-12.93M-31.49%-15M-19.37%-11.46M-58.09%-43.95M-29.32%-11.35M-82.76%-11.6M-63.42%-11.41M
Basic earnings per share 25.00%-0.426.64%-2.396.06%-0.6219.12%-0.552.99%-0.650.00%-0.56-32.64%-2.56-26.92%-0.66-78.95%-0.68-63.41%-0.67
Diluted earnings per share 25.00%-0.426.64%-2.396.06%-0.6219.12%-0.552.99%-0.650.30%-0.56-32.64%-2.56-26.92%-0.66-78.95%-0.68-63.41%-0.67
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions --Unqualified Opinion--------Unqualified Opinion------

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg